Bacterial resistance to present antibiotics is emerging at a high pace that makes the
development of new treatments a must. At the same time, the development of novel …

Bacterial infection remains one of the leading causes of death worldwide, and the options for
treating such infections are decreasing, due the rise of antibiotic-resistant bacteria. The …

This review collates and analyses recent work done on dual action approaches to tackling
the mounting health problem of resistance by human pathogenic bacteria to antibacterial …

Antimicrobial resistance (AMR) has been globally recognized as a threat to human health
and healthcare systems [1]. In fact, AMR is estimated to be responsible for over 700,000 …

Multidrug-resistant (MDR) pathogens pose a well-recognized global health threat that
demands effective solutions; the situation is deemed a global priority by the World Health …

Antimicrobial resistance continues to be a public threat on a global scale. The ongoing need
to develop new antimicrobial drugs that are effective against multi-drug-resistant pathogens …

Infections are a growing global threat, and the number of resistant species of microbial
pathogens is alarming. However, the rapid development of cross-resistant or multidrug …

Drug repurposing is a safe and successful pathway to speed up the novel drug discovery
and development processes compared with de novo drug discovery approaches. Drug …

Multiple approaches have been developed to combat bacterial resistance. However, the
combination of antibiotic resistance mechanisms by bacteria and the limited number of …

Antimicrobial resistance has been a global health challenge that threatens our ability to
control and treat life-threatening bacterial infections. Despite ongoing efforts to identify new …